Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine

Psychopharmacology

Volumn 213, Issue 4, 2011, Pages 757-772

  Jungke, Peggy ^a,c   Ostrow, Gigi ^b   Li, Jian Liang ^b   Norton, Sharon ^b   Nieber, Karen ^c   Kelber, Olaf ^d   Butterweck, Veronika ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d Steigerwald Arzneimittelwerk GmbH   (Germany)

Author keywords

Alzheimer; Antidepressant; Antioxidant; Depression; Fluoxetine; Gene expression; Hippocampus; Hypericum perforatum; Hypothalamus; Microarray; Neuroprotection; St. John's wort; Stress

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN 1; BETA SYNUCLEIN; EXTRACELLULAR SUPEROXIDE DISMUTASE; FLUOXETINE; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE TRANSFERASE M3; HYPERICUM PERFORATUM EXTRACT; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; DRUG DETERMINATION; DRUG ISOLATION; DRUG MECHANISM; DRUG RESPONSE; DRUG TARGETING; GENE EXPRESSION PROFILING; GENE LOCATION; HIPPOCAMPUS; HYPERICUM PERFORATUM; HYPOTHALAMUS; IMMOBILIZATION STRESS; INFLAMMATION; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPERICUM; HYPOTHALAMUS; MALE; MICROARRAY ANALYSIS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79952485718     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2032-3     Document Type: Article

References (69)

1. Ader R, Cohen N (1993) Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol 44:53-85
2. Allantaz F, Chaussabel D, Banchereau J, Pascual V (2007) Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Curr Opin Immunol 19:623-632 (Pubitemid 350236812)
3. Anisman H, Hayley S, Turrin N, Merali Z (2002) Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol 5:357-373 (Pubitemid 35470356)
4. Anisman H, Merali Z, Hayley S (2008) Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85:1-74
5. Avissar S, Schreiber G (2002) Toward molecular diagnostics of mood disorders in psychiatry. Trends Mol Med 8:294-300 (Pubitemid 34568385)
6. Baskys A, Bayazitov I, Zhu E, Fang L, Wang R (2007) Rab-mediated endocytosis: linking neurodegeneration, neuroprotection, and synaptic plasticity? Ann NY Acad Sci 1122:313-329
7. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 57:289-300
8. Brigelius-Flohe R (2006) Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387:1329-1335
9. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
10. Chu TT, Fink MY, Mong JA, John G, Auger AP, Ge Y, Sealfon SC (2007) Effective use of microarrays in neuroendocrine research. J Neuroendocrinol 19:145-161 (Pubitemid 46210942)
11. Cobb MH, Goldsmith EJ (1995) How MAP kinases are regulated. J Biol Chem 270:14843-14846
12. Cooke R, Pate E (1985) The effects of ADP and phosphate on the contraction of muscle fibers. Biophys J 48:789-798 (Pubitemid 16234576)
13. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245 (Pubitemid 34465544)
14. De Ruiter CJ, Van EDEHBG, Wevers RA, De Haan A (2000) Muscle function during fatigue in myoadenylate deaminase-deficient Dutch subjects. Clin Sci (Lond) 98:579-585 (Pubitemid 30261007)
15. De Ruiter CJ, May AM, van Engelen BG, Wevers RA, Steenbergen-Spanjers GC, de Haan A (2002) Muscle function during repetitive moderate-intensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects. Clin Sci (Lond) 102:531-539 (Pubitemid 34494194)
16. Dentino AN, Pieper CF, Rao MK, Currie MS, Harris T, Blazer DG, Cohen HJ (1999) Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 47:6-11 (Pubitemid 29044260)
17. Dierick I, Irobi J, De Jonghe P, Timmerman V (2005) Small heat shock proteins in inherited peripheral neuropathies. Ann Med 37:413-422 (Pubitemid 41476127)
18. Dinamarca MC, Cerpa W, Garrido J, Hancke JL, Inestrosa NC (2006) Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits. Mol Psychiatry 11:1032-1048 (Pubitemid 44631646)
19. Duda JE, Lee VM, Trojanowski JQ (2000) Neuropathology of synuclein aggregates. J Neurosci Res 61:121-127
20. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
21. George JM (2002) The synucleins. Genome Biol 3:REVIEWS3002
22. Goldsmith EJ, Cobb MH (1994) Protein kinases. Curr Opin Struct Biol 4:833-840
23. Grundmann O, Lv Y, Kelber O, Butterweck V (2010) Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system. Neuropharmacology 58:767-773
24. Hu Z, Chen L, Zhang J, Li T, Tang J, Xu N, Wang X (2007) Structure, function, property, and role in neurologic diseases and other diseases of the sHsp22. J Neurosci Res 85:2071-2079 (Pubitemid 47172139)
25. Kalueff AV, Wheaton M, Murphy DL (2007) What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res 179:1-18 (Pubitemid 46441486)
26. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E (2009) Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE 4:e7440
27. Khvotchev MV, Ren M, Takamori S, Jahn R, Sudhof TC (2003) Divergent functions of neuronal Rab11b in Ca2+-regulated versus constitutive exocytosis. J Neurosci 23:10531-10539 (Pubitemid 37485266)
28. Kim KS, Han PL (2006) Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J Neurosci Res 83:497-507
29. Kins S, Lauther N, Szodorai A, Beyreuther K (2006) Subcellular trafficking of the amyloid precursor protein gene family and its pathogenic role in Alzheimer's disease. Neurodegener Dis 3:218-226 (Pubitemid 44600307)
30. Landgrebe J, Welzl G, Metz T, van Gaalen MM, Ropers H, Wurst W, Holsboer F (2002) Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. J Psychiatr Res 36:119-129 (Pubitemid 34218952)
31. Laskowska E (2007) Small heat shock proteins - role in apoptosis, cancerogenesis and diseases associated with protein aggregation. Postepy Biochem 53:19-26
32. Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. Hum Psychopharmacol 24:165-175
33. Linde K (2009) St. John's wort - an overview. Forsch Komplement med 16:146-155
34. Linde K, Berner MM, Kriston L (2008) St John's wort for major depression. Cochrane Database Syst Rev 4:CD000448
35. Mielke K, Herdegen T (2000) JNK and p38 stress kinases - degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61:45-60 (Pubitemid 30100402)
36. Miller F, Fenart L, Landry V, Coisne C, Cecchelli R, Dehouck MP, Buee-Scherrer V (2005) The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model. Eur J Neurosci 22:835-844 (Pubitemid 41243325)
37. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741
38. Mitra R, Vyas A, Chatterjee G, Chattarji S (2005) Chronic-stress induced modulation of different states of anxiety-like behavior in female rats. Neurosci Lett 383:278-283 (Pubitemid 40805570)
39. Mizuguchi T, Hashimoto R, Itokawa M, Sano A, Shimokawa O, Yoshimura Y, Harada N, Miyake N, Nishimura A, Saitsu H, Sosonkina N, Niikawa N, Kunugi H, Matsumoto N (2008) Microarray comparative genomic hybridization analysis of 59 patients with schizophrenia. J Hum Genet 53:914-919
40. Morgan MA, Ganser A, Reuter CW (2007) Targeting the RAS signaling pathway in malignant hematologic diseases. Curr Drug Targets 8:217-235
41. Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J (2008) Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci Ther 14:153-164 (Pubitemid 351713316)
42. Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G (2007) Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets 6:411-423 (Pubitemid 351486255)
43. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63:530-538
44. Paterniti S, Verdier-Taillefer MH, Dufouil C, Alperovitch A (2002) Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatry 181:406-410 (Pubitemid 35333108)
45. Pav M, Kovaru H, Fiserova A, Havrdova E, Lisa V (2008) Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. Physiol Res 57:151-164
46. Post A, Ackl N, Rucker M, Schreiber Y, Binder EB, Ising M, Sonntag A, Holsboer F, Almeida OF (2006) Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-type dementia versus major depression. Biol Psychiatry 59:858-862
47. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Haroutunian V (2006) Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 63:161-167 (Pubitemid 43213877)
48. Rausch JL, Gillespie CF, Fei Y, Hobby HM, Stoming T, Ganapathy V, Leibach FH (2002) Antidepressant effects on kinase gene expression patterns in rat brain. Neurosci Lett 334:91-94 (Pubitemid 35341629)
49. Ricciarelli R, d'Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M (2004) Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life 56:349-354
50. Sijens PE, Mostert JP, Irwan R, Potze JH, Oudkerk M, De Keyser J (2008) Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging. Psychiatry Res 164:274-282
51. Silva BA, Dias AC, Ferreres F, Malva JO, Oliveira CR (2004) Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity. Neurotox Res 6:119-130
52. Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens RM, Benes FM, Sonntag KC (2009) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 132:1795-1809
53. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
54. Spiker D, Lotspeich LJ, Dimiceli S, Myers RM, Risch N (2002) Behavioral phenotypic variation in autism multiplex families: evidence for a continuous severity gradient. Am J Med Genet 114:129-136 (Pubitemid 34160462)
55. Strekalova T, Spanagel R, Dolgov O, Bartsch D (2005) Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 16:171-180 (Pubitemid 40695006)
56. Surguchov A (2008) Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol 270:225-317
57. Trimble WS, Cowan DM, Scheller RH (1988) VAMP-1: a synaptic vesicle-associated integral membrane protein. Proc Natl Acad Sci USA 85:4538-4542
58. Valdivia A, Perez-Alvarez S, Aroca-Aguilar JD, Ikuta I, Jordan J (2009) Superoxide dismutases: a physiopharmacological update. J Physiol Biochem 65:195-208
59. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810-6818 (Pubitemid 35386438)
60. Wilder RL (1995) Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307-338
61. Windisch M, Hutter-Paier B, Rockenstein E, Hashimoto M, Mallory M, Masliah E (2002) Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides. J Mol Neurosci 19:63-69 (Pubitemid 35021252)
62. Windisch M, Hutter-Paier B, Schreiner E, Wronski R (2004) Beta-synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders? J Mol Neurosci 24:155-165
63. Windisch M, Wolf HJ, Hutter-Paier B, Hofmeister A, Wronski R (2007) Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders? Curr Alzheimer Res 4:446-457
64. Wong ML, O'Kirwan F, Hannestad JP, Irizarry KJ, Elashoff D, Licinio J (2004) St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry 9:237-251 (Pubitemid 38496714)
65. Wu Z, Irizarry RA, Gentlemen R, Murillo FM, Spencer F (2004) A model based background adjustment for oligonucleotide expression arrays. JASA 99:909-917 (Pubitemid 39665934)
66. Xu Y, Wong SH, Zhang T, Subramaniam VN, Hong W (1997) GS15, a 15-kilodalton Golgi soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) homologous to rbet1. J Biol Chem 272:20162-20166 (Pubitemid 27340124)
67. Yamada M, Takahashi K, Tsunoda M, Nishioka G, Kudo K, Ohata H, Kamijima K, Higuchi T, Momose K (2002) Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics J 2:377-382 (Pubitemid 36175800)
68. Yoshimoto M, Iwai A, Kang D, Otero DA, Xia Y, Saitoh T (1995) NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Proc Natl Acad Sci USA 92:9141-9145
69. Zhang T, Wong SH, Tang BL, Xu Y, Peter F, Subramaniam VN, Hong W (1997) The mammalian protein (rbet1) homologous to yeast Bet1p is primarily associated with the pre-Golgi intermediate compartment and is involved in vesicular transport from the endoplasmic reticulum to the Golgi apparatus. J Cell Biol 139:1157-1168 (Pubitemid 27523204)